CymaBay Therapeutics, Inc.
CBAYDelisted Mar 22, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001042074
CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding CymaBay Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 113 | 118 | +5 |
| Shares | 63.8M | 65.2M | +1.40M (+2.2%) |
| Value | $215.7M | $202.8M | −$12.8M (−5.9%) |
New holders (22)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighVista Strategies LLC | 207,307 | $645.0K | 0.41% |
| Caxton Associates LP | 117,902 | $367.0K | 0.04% |
| Connor, Clark & Lunn Investment Management Ltd. | 67,221 | $209.0K | 0.00% |
| Baker Avenue Asset Management, LP | 52,800 | $164.0K | 0.01% |
| MetLife Investment Management | 52,338 | $162.8K | 0.00% |
| Cary Street Partner Investment Advisory LLC | 30,000 | $93.0K | 0.03% |
| Pinnacle Wealth Planning Services, Inc. | 29,223 | $91.0K | 0.02% |
| XTX Topco Ltd | 17,183 | $53.0K | 0.02% |
| Group One Trading, L.P. | 12,391 | $39.0K | 0.00% |
| FMR LLC | 11,275 | $35.0K | 0.00% |
| Great Lakes Advisors, LLC | 10,105 | $31.0K | 0.00% |
| Caption Management, LLC | 10,000 | $31.0K | 0.00% |
| Amalgamated Bank | 8,381 | $26.0K | 0.00% |
| Amalgamated Financial Corp. | 8,381 | $26.0K | 0.00% |
| Metropolitan Life Insurance Co | 6,132 | $19.1K | 0.00% |
| Simplex Trading, LLC | 5,574 | $17.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,517 | $8.00K | 0.00% |
| Quadrant Capital Group LLC | 435 | $1.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 14 | $0 | 0.00% |
| Tradewinds Capital Management, LLC | 35 | $0 | 0.00% |
| Ellevest, Inc. | 44 | $0 | 0.00% |
| Parallel Advisors, LLC | 1 | $0 | 0.00% |
Sold out (17)
Institutions that held CymaBay Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Point72 Asset Management, L.P. | 681,401 | $2.30M |
| Stonepine Capital Management, LLC | 300,000 | $1.01M |
| Massachusetts Financial Services Co | 196,052 | $663.0K |
| Federated Hermes, Inc. | 77,403 | $262.0K |
| Cowen and Company, LLC | 65,600 | $222.0K |
| Sender Co & Partners, Inc. | 61,080 | $206.0K |
| Bank of Montreal | 16,904 | $56.0K |
| Bailard, Inc. | 13,700 | $46.0K |
| New York Life Investments Alternatives | 12,924 | $44.0K |
| Occudo Quantitative Strategies LP | 12,051 | $41.0K |
| Dynamic Technology Lab Private Ltd | 11,074 | $37.0K |
| Squarepoint Ops LLC | 10,273 | $35.0K |
| Vectors Research Management, LLC | 6,000 | $20.0K |
| EverSource Wealth Advisors, LLC | 1,050 | $4.00K |
| Truvestments Capital LLC | 727 | $2.00K |
| Massmutual Trust Co FSB | 178 | $1.00K |
| Amplius Wealth Advisors, LLC | 550 | $1.00K |